“…LyP has an almost excellent prognosis with a 10-year survival rate of up to 100%, with a variable clinical course ranging from a few to frequent relapses [ 5 ]. However, this good prognosis may change in patients with associated cutaneous and systemic lymphomas [ 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 ]. Possible risk factors for secondary lymphomas and the frequency of this association remain unclear [ 7 , 9 , 10 , 11 , 15 , 16 , 17 , 18 ].…”